Answers are grounded in this paper and cite their sources.
Identifies Nf1 as a key genetic driver of malignant hematopoiesis in vivo, highlighting critical pathways.
Systematically interrogating the genetic regulators of long-term hematopoietic stem cell (HSC) function and their roles in malignant transformation in vivo remains a central challenge. We developed and validated a sequential in vivo CRISPR screening platform characterized by high sgRNA recovery after a 5-month reconstitution period and a pioneering pooled secondary transplantation strategy. This system not only identified enriched genes but also modeled the dynamics of clonal evolution. As a robust validation of our platform’s sensitivity, the screen identified Neurofibromin 1 (Nf1 ), a quintessential tumor suppressor, as the dominant hit using a focused transcription factor library. The primary screen recapitulated a myeloproliferative state. Strikingly, the secondary transplantation screen amplified this phenotype and led to malignant hematopoiesis. Thus, this 2-step approach establishes a powerful paradigm for studying the genetic drivers of long-term hematopoiesis and the evolutionary dynamics of hematological malignancies.
No takes yet. Share an insight, caveat, or question.
Yuan et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: